On the 5th of November, the Latvian government approved the allocation of EUR 2.9 million from the budget of the Ministry of ...

GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said on Tuesday, making it the country's first authorized RSV shot for that age ...

Pfizer's earnings were better than investors and management ... Its antiviral pill for treating COVID-19, Paxlovid, and its COVID vaccine, Comirnaty, are also performing a bit more strongly than it ...

Is Australian flu dangerous for the brain? This new flu variant, along with RSV, Covid, and pneumococcal pneumonia, are the ...

Is the Australian flu dangerous for the brain? This new flu variant, along with RSV, Covid, and pneumococcal pneumonia, are ...

Some health experts say Kennedy, even in an informal role, could potentially lead to real consequences for patients, ...

attracting the attention of activist investor Starboard Value - which has questioned Pfizer’s returns from a string of recent ...

The earnings season for the drug/biotech sector is now in its final lap, with some large biotech and generic drug companies due to report their third-quarter 2024 results this week. The remaining ...

Shares of Pfizer (NYSE: PFE) are currently trading 12% above their ... The global blue chip biopharma company is attempting ...

Since early January, Luxembourg has destroyed just over a quarter of a million doses of Covid-19 vaccines.

One good income source is dividends. Here are three dividend payers to consider. Pfizer's dividend recently yielded 5.9%, and CEO Albert Bourla has said that "I want to reinforce our commitment to ...

Final judgment was entered on a settlement between Ascension Michigan affiliates and a class of employees denied religious ...